Live price for Apex AI (APEX) is $0.000353, a 2.77% increase over the last 24 hours.
Latest 24h volume: Apex AI (APEX) at $3.5K, an increase of 2.77% since yesterday.
Its current market capitalization is approximately $339.5K. Liquidity across major Solana DEXes is currently at $85.6K.
APEX is actively traded in Solflare wallet. The token is unverified according to Solana's token registry. This token can be swapped instantly on Solflare for any other supported asset. You can also set advanced limit orders for this token directly within the Solflare wallet, allowing you to automate trades based on your chosen price targets.
Market Data for Apex AI
Market Cap
339.53K
Volume 24h
3.46K
2.77%
FDV
347.93K
Liquidity
85.58K
Max Supply
1.00B
Circulating Supply
962.92M
Apex AI token risks overview
Mintable - Indicates if more tokens can be created after the initial launch.
Mintable
No
Mutable - Enables changes to the token’s metadata after creation.
Mutable
Yes
Freezable - Grants control to freeze token accounts and prevent transfers.
Freezable
No
Top holders - Percentage of the total supply held by the 20 largest wallets.
Top Holders %
55.04%
Total holders
7,315
Last risk check date
1/15/2026, 10:38:10 PM
About Apex AI APEX
Apex AI is an artificial intelligence-driven healthcare startup focused on revolutionizing early detection and predictive diagnostics for gastrointestinal cancers, specifically stomach and colorectal cancer. Apex AI leverages advanced machine learning algorithms and extensive datasets comprising over 1 million endoscopic images to significantly enhance diagnostic accuracy, achieving 95%+ accuracy for stomach cancer and 98%+ for colorectal cancer. The platform provides real-time AI-powered endoscopic analysis, continuous disease monitoring, and precise risk assessment, helping clinicians identify early-stage cancers and precancerous lesions effectively. Apex AI aims to bridge the existing diagnostic gap caused by human error, asymptomatic disease progression, and limited early-stage detection capabilities, ultimately improving patient survival rates and clinical outcomes worldwide.